Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence

Saved in:

Bibliographic Details
Published in:	Canadian journal of cardiology Vol. 36; no. 8; pp. 1180 - 1182
Main Authors:	Turgeon, Ricky D., Zieroth, Shelley, Bewick, David, Chow, Chi-Ming, Clarke, Brian, Cowan, Simone, Fordyce, Christopher B., Fournier, Anne, Gin, Kenneth, Gupta, Anil, Hardiman, Sean, Jackson, Simon, Lau, Benny, Leong-Poi, Howard, Mansour, Samer, Marelli, Ariane, Quraishi, Ata Rehman, Roifman, Idan, Ruel, Marc, Sapp, John, Singh, Gurmeet, Small, Gary, Virani, Sean, Wood, David A., Krahn, Andrew
Format:	Journal Article
Language:	English
Published:	England Elsevier Inc 01.08.2020 Canadian Cardiovascular Society. Published by Elsevier Inc
Subjects:	Angiotensin II Type 1 Receptor Blockers - pharmacology Angiotensin-Converting Enzyme 2 Angiotensin-Converting Enzyme Inhibitors - pharmacology Betacoronavirus - physiology Coronavirus Infections - epidemiology Coronavirus Infections - therapy Coronavirus Infections - virology COVID-19 Heart Failure - drug therapy Humans Hypertension - drug therapy Journal and Pandemics Patient Care Management Peptidyl-Dipeptidase A - metabolism Pneumonia, Viral - epidemiology Pneumonia, Viral - therapy Pneumonia, Viral - virology Practice Guidelines as Topic Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology SARS-CoV-2 Virus Internalization - drug effects
ISSN:	0828-282X, 1916-7075, 1916-7075
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	0828-282X 1916-7075 1916-7075
DOI:	10.1016/j.cjca.2020.05.033